1 / 12

Drug database and performance indicators for utilization monitoring

This study focuses on the utilization of drugs in hospitals using a drug database. It identifies key performance indicators such as total purchases, ratio of essential drugs to non-essential drugs, and unit price statistics. The findings highlight the need for better data management and policy implementations in drug utilization.

howea
Download Presentation

Drug database and performance indicators for utilization monitoring

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Drug database and performance indicators for utilization monitoring by Petcharat Pongcharoensuk, et al. Faculty of Pharmacy, Mahidol University e-mail: pyppn@mahidol.ac.th Sponsor: The National Health Security Office ICIUM2004_CM

  2. Introduction • Drugs, 30% of health expenses • Drug database in hospitals (purchasing and dispensing) • Limited utility • Lack standard format and code • Insufficient information technology “Drug information for decision making” ICIUM2004_CM

  3. Objective • To determine key performance indicators for drug utilization monitoring • Total purchase • ratio ED:NED • by drug group, etc. • Unit price statistics ICIUM2004_CM

  4. Methodology • Sample: 26 public hospitals (10-1000 bed) • 5 small, 21 medium and large • Source: Electronic purchase database (2000-2002) • Data transformation (mapping different codes into standard code) • Data consolidation and analysis ICIUM2004_CM

  5. Results: Key performance indicators I. Total drug purchase (million baht) -------------------------------------------- Year Purchase%change (adjusted*) (adjusted*) --------------------------------------------- 2000 817.8 2001 908.3(898.4)11.0(9.9) 2002 978.4(947.7)7.7(5.6) ----------------------------------------- Notes: *adjusted for inflation of 1.1% in 2001 and 1.9% in 2002 (NESDB). ICIUM2004_CM

  6. II. Drug as % total expenses, 2002 ----------------------------------------------- Type of Hospital (bed) N Range % Avg. ----------------------------------------------- Regional (500-1000) 7 15.6-29.4 20.7 General (200-500) 14 11.2-27.2 18.3 Community (10-90) 5 12.5-19.6 17.5 ----------------------------------------------- ICIUM2004_CM

  7. III. Ratio NED:ED ----------------------------------------- Year Ratio (NED:ED) ----------------------------------------- 2000 15 : 85 2001 17 : 83 2002 18 : 82 ----------------------------------------- ICIUM2004_CM

  8. IV. Pharmacological sub-groups (%) ----------------------------------------------- Rank Group 2002 2001 2000 ----------------------------------------------- 1 Anti-bacterials21.6 23.8 26.6 3 Anti-asthma 4.0 4.4 3.9 4 Anti-diabetics 3.9 3.3 3.0 5 Hypo-lipidemic 3.3 2.8 2.4 6 Anti-anaemic 3.3 2.7 2.1 8 NSAIDS 2.5 2.6 2.0 10 Cytostatic 2.2 1.7 1.4 ----------------------------------------------- Total (million) 824 779 730 ----------------------------------------------- ICIUM2004_CM

  9. V. Unit price statistics --------------------------------------------------- Drug N Min Max Avg. p50 p75 --------------------------------------------------- Aledronate 10 mg tab 48 45.9 81.7 49.0 48.2 48.2 Alprazolam .25 mg tab 44 0.2 5.0 0.7 0.5 0.8 Atorvastatin 20 mg tab 32 50.3 58.4 52.3 50.3 52.3 Captopril 25 mg tab 27 1.4 26.3 6.1 7.5 7.5 Cefoperazone 1 g inj 65 220 487 422 486 486 Ceftriaxone 1 g inj 22 20.2 124 36.6 31.0 38.0 Ciprofloxacin 250 mg tab 59 1.2 14.1 4.2 3.8 5.4 Simvastatin 10 mg tab 66 2.0 8.9 4.7 4.2 5.4 Rosiglitazone 4 mg tab 12 57.3 87.9 59.9 57.3 57.3 --------------------------------------------------- ICIUM2004_CM

  10. Discussions • Lesson learned • Urgent need for data management and policy implementations • Policy implications • Central data warehouse (MoPH?) • Agency for standard drug code(FDA?) • Quantity and quality indicators ICIUM2004_CM

  11. Recommendations • Research • Cost of illness and quality of drug use • Outcomes of treatment • Systematic management of drugs ICIUM2004_CM

  12. Acknowledgement Team Mr Mungorn Angsanant Ms Pornpimol Chantarakunopars Preeyaporn Phutong Siritorn Kongsawat Etc. ICIUM2004_CM

More Related